Delivery Order SPE2DB20D2014-SPE2DB25FC50A
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,169.62 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 10 mg capsules (100 count). The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,148.12 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count) with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. government's Defense Logistics Agency (DLA) awarded a $1,046.82 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,561,655,726 units of the prescription drug Dexmethylphenidate ER 10 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,135,189 units of Dexmethylphenidate ER 10 mg capsules. The $2,805.96 contract has an ultimate completion date of April 2, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its corporate office located in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,104.25 firm fixed-price delivery order is for the supply of 100 units of the pharmaceutical product Dexmethylphenidate ER 20 mg capsules. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a $62,000 delivery order contract to Amerisourcebergen Drug Corporation to provide 100 units of 15mg dexmethylphenidate ER capsules. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the three-day period of July 7-10, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency functions to support military readiness by procuring and...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,237.10 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,625,337 units of Dexmethylphenidate ER 10 mg capsules. The contract is a firm fixed-price agreement with an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $126,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Dexmethylphenidate ER 25 mg capsules. Under this single award, Amerisourcebergen will deliver 100 units of the specified controlled substance to a facility in Conshohocken, Pennsylvania by September 27, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for extended release capsules of a stimulant medication was...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,240,637 units of Dexmethylphenidate ER 10 mg capsules. The firm-fixed-price contract has a total ceiling value of $1,594.92 and a completion date of July 25, 2024. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medications and medical supplies...
- This is a $14,605.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,007,300 units of dexmethylphenidate ER 10 mg capsules, a neurological medication. The contract is not designated as a set-aside and has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC50ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,433.30 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of medications and medical supplies. The company holds significant capacity to fulfill federal medical requirements across multiple therapeutic domains, including specialty medications, generic and brand-name drugs, and medical devices. This particular delivery order for Dexmethylphenidate—a prescription stimulant medication typically used for attention deficit disorders—represents routine pharmaceutical procurement supporting military medical operations and troop healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/18/25 |